Milind Deshpande
2014
In 2014, Milind Deshpande earned a total compensation of $4.9M as Director, President and Chief Executive Officer at Achillion Pharmaceuticals, a 16% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $384,860 |
|---|---|
| Option Awards | $4,070,653 |
| Salary | $484,100 |
| Other | $8,124 |
| Total | $4,947,737 |
Deshpande received $4.1M in option awards, accounting for 82% of the total pay in 2014.
Deshpande also received $384.9K in non-equity incentive plan, $484.1K in salary and $8.1K in other compensation.
Rankings
In 2014, Milind Deshpande's compensation ranked 1,586th out of 13,032 executives tracked by ExecPay. In other words, Deshpande earned more than 87.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,586 out of 13,032 | 88th |
Division Manufacturing | 567 out of 4,965 | 89th |
Major group Chemicals And Allied Products | 181 out of 1,690 | 89th |
Industry group Drugs | 141 out of 1,369 | 90th |
Industry Pharmaceutical Preparations | 121 out of 1,042 | 88th |
Source: SEC filing on April 17, 2017.
Deshpande's colleagues
We found four more compensation records of executives who worked with Milind Deshpande at Achillion Pharmaceuticals in 2014.
2014
David Apelian
Achillion Pharmaceuticals
Chief Medical Officer
2014
Joseph Truitt
Achillion Pharmaceuticals
Executive Vice President and Chief Commercial Officer
2014
Mary Fenton
Achillion Pharmaceuticals
Chief Financial Officer
2014
Gautam Shah
Achillion Pharmaceuticals